FindTrial
Sign In

A Study to Evaluate the Effect of a 90-Day Lifestyle Change Program in People with Type 2 Diabetes

Effectiveness of Madhavbaugs Comprehensive Diabetes Care Program: A Retrospective Multi-Center Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/107663
Enrollment
19564
Registered
2026-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Vaidya Sane Ayurved Laboratories Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Adult patients greater than 18 years of age with Type 2 Diabetes Mellitus 2) Enrolled in Madhavbaug CDC program between April 2019 and July 2025 3) Completed 90-day CDC program 4) Valid paired HbA1c measurements, both at baseline and at Day 90 5) HbA1c values within physiologically valid range 4 to 15

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Change in Glycated HemoglobinTimepoint: Baseline - Day 0 and Day 90 - 3 months—

Secondary

MeasureTime frame
To assess changes in anthropometric parameters -Weight, BMI, Abdominal GirthTimepoint: Baseline - Day 0 and Day 90 - 3 months—

Countries

India

Contacts

Public ContactDr Pravin Ghadigaonkar

Vaidya Sane Ayurved Laboratories Limited

drpravin@madhavbaug.com9820167846

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026